AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese

Construction and Validation of Outcome Indicators Set for Hybrid Type 1 Implementation Research: Based on the SMART Study

Lang LINGHU1,2Yiyuan CAI1,2( )Dong XU3,4,5
AcaciaLab for Primary Healthcare, Department of Epidemiology and Health Statistics, School of Publi Health, Guizhou Medical University, Guiyang 561113, China
The key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang 561113, China
Acacia Lab for lmplementation Science, Department of Health Management, School of Health Management, Southern Medical University, Guangzhou 510515, China
Southern Medical University Institute for Global Health (SIGHT), Dermatology Hospital of Southemm Medical University, Guangzhou 510091, China
Center for World Health Organization Studies, Southern Medical University, Guangzhou 510515, China
Show Author Information

Abstract

Objective

Using the hybrid type 1 implementation study "The Shared Medical Appointment for diabetes in China: an optimization trial(SMART)" as an example, this study introduces the methods of constructing and validating an outcome indicator set for hybrid type 1 studies.

Methods

Based on principles such as comprehensiveness and operability, we selected the RE-AIM (reach, effectiveness, adoption, implementation, maintenance) framework, the Implementation Outcomes Framework (IOF), and the PRECEDE-PROCEED model. After comparison and screening, an outcome evaluation indicator item pool was formed. Two rounds of expert consultation were conducted, and the content validity was evaluated using the item-level content validity index (I-CVI), coefficient of variation (CV), and adjusted Kappa value, combined with experts' qualitative opinions and on-site implementation to optimize the indicators.

Results

This study integrated the RE-AIM framework and three pre-evaluation dimensions from the IOF, forming an initial item pool for shared medical appointments (SMA) that included 8 dimensions (acceptability, appropriateness, feasibility, reach, effectiveness, adoption, implementation, and maintenance), 14 secondary indicators, and 24 tertiary indicators. The response rate of the two rounds of expert consultation was 100%, with an expert authority coefficient of 0.90. The I-CVI ranged from 0.75 to 1.00, the CV from 0 to 0.32, and the adjusted Kappa from 0.75 to 1.00, indicating good content validity and high expert consensus. After two rounds of consultation, one secondary indicator and three tertiary indicators were deleted, one new secondary indicator was added, and the dimension attribution of one indicator was adjusted. Following pilot implementation and stakeholder feedback, two tertiary indicators were added, four were deleted, and the measurement tool of one indicator was adjusted. The finalized implementation outcome indicator set for the SMART study comprises 8 dimensions, 14 secondary indicators, and 19 tertiary indicators.

Conclusions

The outcome indicator set constructed in this study demonstrates good validity and operability, and the construction and validation process can serve as a reference for other researchers. Different implementation outcome frameworks have different applicable scenarios; researchers should select appropriate frameworks or integrate them according to their own needs to comprehensively evaluate outcomes and enhance the systematization and comparability of research.

CLC number: R587.1;R-05 Document code: A Article ID: 1674-9081(2026)03-0871-12

References

【1】
【1】
 
 
Medical Journal of Peking Union Medical College Hospital
Pages 871-882

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
LINGHU L, CAI Y, XU D. Construction and Validation of Outcome Indicators Set for Hybrid Type 1 Implementation Research: Based on the SMART Study. Medical Journal of Peking Union Medical College Hospital, 2026, 17(3): 871-882. https://doi.org/10.12290/xhyxzz.2025-1288

94

Views

0

Downloads

0

Crossref

0

Scopus

0

CSCD

Received: 07 December 2025
Accepted: 06 May 2026
Published: 22 May 2026
© 2026 Medical Journal of Peking Union Medical College Hospital